Pharmaceutical tenders

In Germany statutory health insurances can conclude a so-called pharmaceutical tender with pharmaceutical manufactures. This legal option has existed since 2003. In addition, an amendment in 2007 obliges pharmacists to dispense rebated pharmaceuticals, provided that this has not been ruled out by the doctor.

Within the framework of the pharmaceutical tender, a pharmaceutical company gives a certain discount to the health insurance for a single pharmaceutical product on the nationwide standard pharmacy retail price of up to two years. In the pharmacy the preparations have to be preferably dispensed to the members of the health insurance. This is also the case when products with the same active could alternatively be dispensed.

Thus, pharmaceutical tenders enable savings in the healthcare system in order to promote competition. According to the German Federal Ministry of Health, pharmaceutical tenders resulted in savings of EUR 3.15 billion in 2014.

We are delighted to inform you about our rebated pharmaceuticals. Therefore please use our contact form.

There are currently pharmaceutical tenders between HAEMATO PHARM and the following public health insurance companies:








Die HAEMATO AG ist ein börsennotiertes pharmazeutisches Unternehmen mit Fo-kus auf die Wachstumsmärkte patentfreier und patentgeschützter Arzneimittel...


IFRS-Ergebnis Q1 2017, Umsatz 67,9 Mio. Euro (Vorjahresperiode: 67,9 Mio. Euro), EBIT 2,8 Mio. Euro (Vorjahresperiode: 3,5 Mio. Euro)...


2016: Vorläufiges IFRS-Ergebnis, Umsatzwachstum 20% auf 275,6 Mio. Euro, EBIT-Wachstum (operatives Ergebnis) 63% auf 13,4 Mio. Euro;...

Order service - Telephone: +49 30 677 98 67 60
Aktuelle News